Metraipolis › archive › dc_b83dd7636855

Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System) — Europe PMC PMID:42782877

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42782877
DOI
10.3390/curroncol33090530
License (as archived)
solo-consultazione
Archived
2026-10-16T06:19:46.300Z
SHA-256 of the archived text
d1f30283b6a7d0d5901e3e5eef4baea59c8b27ea0d2081cf6acb7b652895cd9e
Stable URL of this page
https://metraipolis.com/documento/dc_b83dd7636855

How to cite

Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System) — Europe PMC PMID:42782877 — Europe PMC (en), https://europepmc.org/article/MED/42782877 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b83dd7636855 (Metraipolis archive dc_b83dd7636855, sha256 d1f30283b6a7d0d5901e3e5eef4baea59c8b27ea0d2081cf6acb7b652895cd9e)
BibTeX
@misc{dcb83dd7636855,
  title = {Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System) — Europe PMC PMID:42782877},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42782877},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b83dd7636855; sha256 d1f30283b6a7d0d5901e3e5eef4baea59c8b27ea0d2081cf6acb7b652895cd9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42782877. Agents can read the archived copy with the MCP tool read_document.